We are pleased to announce the entry of Biotech Investissement into the capital of SMALTIS SAS, a company based in Besançon (France), which joins RD-Biotech SAS, Diaclone SAS, SynAbs SA and QVQ Holding within the group (www.mabexperts.com).
Read more